Find the original research

Live search across PubMed, the U.S. National Library of Medicine's citation database, and ClinicalTrials.gov. We show what each record is and link you to it; we don't summarise findings or rank studies by what they conclude.

Published studies · PubMed Clinical trials · ClinicalTrials.gov

Condition or keywords

Compound (intervention)

Status

Any statusRecruitingActive, not recruitingCompletedStopped early

Phase

Sort

No peptide sellers, no affiliate links, ads clearly labelled Every claim cited to a primary source Reviewed and dated No dosing protocols

Pep-Calc

Peptides, explained. Educational information only — not medical advice.

Platform

Peptides Research Lab Learn Calculator News Ask Compare Glossary

Research tools

Research discovery Research feed Academy Workspace

Standards

Methodology Disclaimer Privacy

Published studies · PubMed Clinical trials · ClinicalTrials.gov

Condition or keywords

Compound (intervention)

Status

Any statusRecruitingActive, not recruitingCompletedStopped early

Phase

Sort

1 registered study

Verify this search on the official site ↗ · fetched Nov 4, 2026, 7:54 PM UTC

Status on this page

Active / recruiting 1Completed 0Stopped early 0Other 0

A registered trial is a plan, not a result. “Results posted” means the sponsor uploaded summary results to the registry; it says nothing about whether the treatment worked.

RecruitingPhase 1 / Phase 2interventionalNCT07487363
TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD (opens ClinicalTrials.gov)
Sponsor
Hudson Biotech
Enrolment
80
Started
2026-02-05
Last update
2026-03-23
Conditions: Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction
Interventions: TB-500, Placebo
View registration ↗

Find the original research

TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD (opens ClinicalTrials.gov)